Cargando…
A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
Biomimetic strategies are useful for designing potent vaccines. Decorating a nanoparticulate adjuvant with cell membrane fragments as the antigen‐presenting source exemplifies, such as a promising strategy. For translation, a standardizable, consistent, and scalable approach for coating nanoadjuvant...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336609/ https://www.ncbi.nlm.nih.gov/pubmed/34386315 http://dx.doi.org/10.1002/advs.202002020 |
_version_ | 1783733353948643328 |
---|---|
author | Hu, Hanze Yang, Chao Zhang, Fan Li, Mingqiang Tu, Zhaoxu Mu, Lizhong Dawulieti, Jianati Lao, Yeh‐Hsing Xiao, Zixuan Yan, Huize Sun, Wen Shao, Dan Leong, Kam W. |
author_facet | Hu, Hanze Yang, Chao Zhang, Fan Li, Mingqiang Tu, Zhaoxu Mu, Lizhong Dawulieti, Jianati Lao, Yeh‐Hsing Xiao, Zixuan Yan, Huize Sun, Wen Shao, Dan Leong, Kam W. |
author_sort | Hu, Hanze |
collection | PubMed |
description | Biomimetic strategies are useful for designing potent vaccines. Decorating a nanoparticulate adjuvant with cell membrane fragments as the antigen‐presenting source exemplifies, such as a promising strategy. For translation, a standardizable, consistent, and scalable approach for coating nanoadjuvant with the cell membrane is important. Here a turbulent mixing and self‐assembly method called flash nanocomplexation (FNC) for producing cell membrane‐coated nanovaccines in a scalable manner is demonstrated. The broad applicability of this FNC technique compared with bulk‐sonication by using ten different core materials and multiple cell membrane types is shown. FNC‐produced biomimetic nanoparticles have promising colloidal stability and narrow particle polydispersity, indicating an equal or more homogeneous coating compared to the bulk‐sonication method. The potency of a nanovaccine comprised of B16‐F10 cancer cell membrane decorating mesoporous silica nanoparticles loaded with the adjuvant CpG is then demonstrated. The FNC‐fabricated nanovaccines when combined with anti‐CTLA‐4 show potency in lymph node targeting, DC antigen presentation, and T cell immune activation, leading to prophylactic and therapeutic efficacy in a melanoma mouse model. This study advances the design of a biomimetic nanovaccine enabled by a robust and versatile nanomanufacturing technique. |
format | Online Article Text |
id | pubmed-8336609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83366092021-08-11 A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines Hu, Hanze Yang, Chao Zhang, Fan Li, Mingqiang Tu, Zhaoxu Mu, Lizhong Dawulieti, Jianati Lao, Yeh‐Hsing Xiao, Zixuan Yan, Huize Sun, Wen Shao, Dan Leong, Kam W. Adv Sci (Weinh) Communications Biomimetic strategies are useful for designing potent vaccines. Decorating a nanoparticulate adjuvant with cell membrane fragments as the antigen‐presenting source exemplifies, such as a promising strategy. For translation, a standardizable, consistent, and scalable approach for coating nanoadjuvant with the cell membrane is important. Here a turbulent mixing and self‐assembly method called flash nanocomplexation (FNC) for producing cell membrane‐coated nanovaccines in a scalable manner is demonstrated. The broad applicability of this FNC technique compared with bulk‐sonication by using ten different core materials and multiple cell membrane types is shown. FNC‐produced biomimetic nanoparticles have promising colloidal stability and narrow particle polydispersity, indicating an equal or more homogeneous coating compared to the bulk‐sonication method. The potency of a nanovaccine comprised of B16‐F10 cancer cell membrane decorating mesoporous silica nanoparticles loaded with the adjuvant CpG is then demonstrated. The FNC‐fabricated nanovaccines when combined with anti‐CTLA‐4 show potency in lymph node targeting, DC antigen presentation, and T cell immune activation, leading to prophylactic and therapeutic efficacy in a melanoma mouse model. This study advances the design of a biomimetic nanovaccine enabled by a robust and versatile nanomanufacturing technique. John Wiley and Sons Inc. 2021-05-01 /pmc/articles/PMC8336609/ /pubmed/34386315 http://dx.doi.org/10.1002/advs.202002020 Text en © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Communications Hu, Hanze Yang, Chao Zhang, Fan Li, Mingqiang Tu, Zhaoxu Mu, Lizhong Dawulieti, Jianati Lao, Yeh‐Hsing Xiao, Zixuan Yan, Huize Sun, Wen Shao, Dan Leong, Kam W. A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines |
title | A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines |
title_full | A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines |
title_fullStr | A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines |
title_full_unstemmed | A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines |
title_short | A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines |
title_sort | versatile and robust platform for the scalable manufacture of biomimetic nanovaccines |
topic | Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336609/ https://www.ncbi.nlm.nih.gov/pubmed/34386315 http://dx.doi.org/10.1002/advs.202002020 |
work_keys_str_mv | AT huhanze aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT yangchao aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT zhangfan aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT limingqiang aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT tuzhaoxu aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT mulizhong aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT dawulietijianati aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT laoyehhsing aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT xiaozixuan aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT yanhuize aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT sunwen aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT shaodan aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT leongkamw aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT huhanze versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT yangchao versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT zhangfan versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT limingqiang versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT tuzhaoxu versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT mulizhong versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT dawulietijianati versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT laoyehhsing versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT xiaozixuan versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT yanhuize versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT sunwen versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT shaodan versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines AT leongkamw versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines |